Latigo Biotherapeutics, Inc. (LTGO)
21.08
-1.47
(-6.52%)
USD |
NASDAQ |
Sep 21, 16:00
20.70
-0.38
(-1.80%)
After-Hours: 20:00
Latigo Biotherapeutics Total Assets (Quarterly) : 64.76M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.76M |
| Date | Value |
|---|---|
| March 31, 2026 | 50.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.26M |
| Shareholders Equity (Quarterly) | 12.50M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 1.148 |